Next Article in Journal
Utilisation of Group-Based Diabetes Education Programmes: Perspectives of Healthcare Practitioners
Previous Article in Journal
A Qualitative Analysis of First-Year Dental Students’ Opinions on Diabetes Screening in the Dental Setting
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Dutch HbA1c Lifestyle Study (DAF-Study): Seasonal Variation of HbA1c in the Dutch Diabetes Population—Associations with Macronutrient Intake and Physical Activity

by
Erwin Kemna
1,*,
Henk Bilo
2,
Martine Deckers
3,
Christiaan Slim
4,
Annemarieke Loot
5,
Linda M. Henricks
6,7,
Jacoline Brinkman
8,
Jody van den Ouweland
9,
Steef Kurstjens
9,10,
Madeleen Bosma
6,11,
Iris van Vlodrop
12,
Pauline Verschuure
13,
Jurgen Kooren
14,
Stefan Coolen
15,
Karin Mohrmann
16,
Martin Schuijt
8,17,
Johannes Krabbe
18,
Robert Wever
19,
Marlies Oostendorp
20,
Ivon van der Linden
21,
Margriet van Kogelenberg
22,
Margo Molhoek
23,
Mieke Koenders
24,
Silvia Endenburg
25,
Roseri de Beer
26 and
Cas Weykamp
1,27
add Show full author list remove Hide full author list
1
Department of Clinical Chemistry and Hematology, Queen Beatrix Hospital, 7100 GG Winterswijk, The Netherlands
2
Diabetes Centre, Department of Internal Medicine, University of Groningen, University Medical Centre Groningen, 9713 GZ Groningen, The Netherlands
3
Department of Clinical Chemistry, OLVG Lab, 1061 AE Amsterdam, The Netherlands
4
Department of Clinical Chemistry, Certe Medical Diagnostic & Advice, 9728 NT Groningen, The Netherlands
5
Laboratory of Clinical Chemistry and Hematology, Accureon B.V., 4462 RA Goes, The Netherlands
6
Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands
7
Central Diagnostic Laboratory, Department of Laboratory Medicine, Amsterdam University Medical Centre, 1105 AZ Amsterdam, The Netherlands
8
Department of Clinical Chemistry, Hospital St. Jansdal, 3840 AC Harderwijk, The Netherlands
9
Department of Clinical Chemistry, Dicoon B.V., Location Canisius-Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands
10
Laboratory of Clinical Chemistry and Hematology, Jeroen Bosch Hospital, 5223 GZ Den Bosch, The Netherlands
11
Eurofins SCAL, 2321 CT Leiden, The Netherlands
12
Laboratory of Clinical Chemistry, Haga Teaching Hospital, 2545 AA The Hage, The Netherlands
13
Clinical Laboratory, Anna Hospital, 5664 EH Geldrop, The Netherlands
14
Department of Clinical Chemistry, Unilabs/Atalmedial Medical Diagnostic Centers, 1066 EC Amsterdam, The Netherlands
15
Laboratorio de Médicos (LabdeMed), Willemstad, Curaçao
16
Star-Shl, 3068 JE Rotterdam, The Netherlands
17
Department of Clinical Chemistry, Slingeland Hospital, 7009 BL Doetinchem, The Netherlands
18
Department of Clinical Chemistry and Laboratory Medicine, Medisch Spectrum Twente, Medlon B.V., 7512 KZ Enschede, The Netherlands
19
Medical Laboratory Services, Willemstad, Curaçao
20
Department of Clinical Chemistry and Immunology, Dicoon B.V., Location Rijnstate Hospital, 6815 AD Arnhem, The Netherlands
21
Laboratory of Clinical Chemistry and Hematology, Siemens Healthineers, 5406 PT Uden, The Netherlands
22
Department of Clinical Chemistry and Hematology, Gelre Hospitals, 7334 DZ Apeldoorn, The Netherlands
23
Diagnostiek Voor U, 5626 AG Eindhoven, The Netherlands
24
Clinical Chemistry, Elkerliek Hospital, 5707 HA Helmond, The Netherlands
25
Clinical Chemistry and Hematology Laboratory, Dicoon B.V., Location Gelderse Vallei Hospital, 6716 RP Ede, The Netherlands
26
Laboratory for Medical Diagnostics, Rivierenland Hospital, 4002 WP Tiel, The Netherlands
27
European Reference Laboratory, Location Queen Beatrix Hospital, 7100 GG Winterswijk, The Netherlands
*
Author to whom correspondence should be addressed.
Diabetology 2025, 6(11), 135; https://doi.org/10.3390/diabetology6110135
Submission received: 30 July 2025 / Revised: 17 September 2025 / Accepted: 28 October 2025 / Published: 3 November 2025

Abstract

Background/Objectives: Seasonal variation in hemoglobin A1c (HbA1c) values has been previously documented, with physical activity (PA) and macronutrient intake (MNI) suggested as potential drivers. This study combines seasonal mean HbA1c values from the Dutch (pre)diabetes population with national survey data on PA and MNI from 2018 to 2021 to identify key associations. Methods: HbA1c data were collected from 24 laboratory organizations in the Netherlands and Dutch Caribbean. MNI and total energy intake data were extracted from the Dutch National Food Consumption Survey, while PA data came from the Dutch National Sports Participation Index Survey. Weighting factors were applied to align PA and MNI data with HbA1c data. Seasonal averages were analyzed for significant differences, and a prediction model compared PA and MNI with actual HbA1c values. Results: Among 5,635,920 HbA1c results, the average HbA1c increased by 0.71 mmol/mol (NGSP 0.06%) over four years, with an overall mean of 52.4 mmol/mol (NGSP 7.0%). Seasonal HbA1c variation showed a dip in summer–autumn and a peak in winter–spring (1.2 mmol/mol; NGSP 0.11%; p < 0.0001). MNI, except for total energy intake (which peaked in summer; p < 0.001), showed no significant trends or association with HbA1c (p = 0.157). PA decreased by 7.2% over the study period, with seasonal peaks in summer–autumn, showing an inverse relationship with HbA1c (p < 0.0001). During the COVID-19 lockdowns, PA significantly decreased, and mean HbA1c values increased more markedly than in previous years. The prediction model confirmed PA as a significant driver of seasonal HbA1c variation (p = 0.004). Conclusions: These findings suggest that PA is the strongest driver of seasonal variation in HbA1c. Public health initiatives and support programs promoting physical activity are essential for improving HbA1c regulation.

Graphical Abstract

1. Introduction

Diabetes mellitus (DM) is one of the most common chronic diseases, with a rising global prevalence [1]. Hallmark studies from the Diabetes Control and Complications Trail Group and UK Prospective Diabetes Study show that adequate glycemic control is essential for preventing or delaying both acute and chronic complications of diabetes [2,3]. Much more insight has been gained on diabetes prevention and control since then, and is now included in guidelines and clinical recommendations from the ADA and EASD [4,5]. Hemoglobin A1c (HbA1c) is a key biomarker that reflects average blood glucose levels over the preceding two months and is therefore used to assess long-term glucose control and predict diabetes-related complications.
Successful standardization [6], combined with increasingly accurate and precise measurement techniques, has enabled the use of HbA1c not only as a prognostic indicator but also as a diagnostic parameter for DM [7]. In the late 1980s, the first reports emerged describing seasonal variability in HbA1c levels, typically showing a circannual pattern with higher values in winter and lower values in summer [8,9,10,11,12,13]. This pattern is observed both above and below the equator, with greater peak-to-trough amplitudes at higher latitudes. In contrast, smaller or negligible differences are seen in equatorial regions [14,15].
Key factors contributing to this variation include physical activity (PA) and macronutrient intake (MNI; carbohydrate, fat, and protein), both of which can vary seasonally [16]. Carbohydrate intake, in particular, has a direct and well-established impact on HbA1c levels [17,18]. The roles of fat and protein intake are less clear [19,20], though evidence suggests that fat intake may have a stronger association with HbA1c than protein intake [21]. While the precise relationships remain unclear and may differ between individuals, seasonal variation in glucose control has important implications for interpreting HbA1c results and, consequently, for managing patients with DM—especially when measurements are taken at varying intervals throughout the year.
In the present study, the Dutch HbA1c Lifestyle Study (DAF-Study), we collected HbA1c data on a national scale over a four-year period including several lockdown periods during the COVID-19 pandemic and compared the results to national survey data on PA and MNI in the Dutch population. To our knowledge, this is the first study to compare these datasets on a national level to investigate whether seasonal variation in HbA1c exists in the Netherlands. The secondary objective was to explore potential associations between HbA1c, PA, and MNI.

2. Materials and Methods

2.1. National HbA1c Data

Retrospective data from January 2018 to December 2021 were anonymized and extracted from the Laboratory Information Systems of 24 laboratory organizations across the Netherlands and the Dutch Caribbean islands of Curaçao and Aruba. Data included HbA1c values, date of sampling, patient age at the time of sampling, and sex. The diabetes status and number of unique individuals were unknown, including pregnancy. HbA1c values are expressed in IFCC units (mmol/mol) ± 95% confidence interval, with NGSP values given in parentheses (%).
For each organization, data were cleaned by removing control samples, incomplete entries, and non-numeric results. Non-numeric entries such as “<“ or “>” were replaced with the corresponding numerical threshold values. Values below 20 mmol/mol (NGSP < 4.0%) were excluded as a result of analytical incorrect measurement or increased erythrocyte turnover. Age values exceeding 110 years were also excluded because of an artificial birthday linkage to control samples. Due to extensive missing data, the complete dataset from Aruba was excluded. Additionally, data from a pancreas transplantation centre were omitted due to a non-representative patient population. All data from Curaçao were excluded from the main dataset due to selection bias (anomalous sex ratio compared to the official data of The Health Institute of Curaçao [22]) and analytical bias, based on annual external quality reports (For details see Section 2.2 HbA1c Analysis). In total, 10% of the initial HbA1c data were excluded.

2.2. HbA1c Analysis

HbA1c measurements were performed using 33 analysers representing four analytical methods: HPLC ion-exchange chromatography (65%), capillary electrophoresis (4%), immunochemistry (22%), and enzymatic assays (9%).
All laboratories participated in the national External Quality Assessment (EQA) Program, which uses whole blood samples of human origin. The production and value assignment of EQA samples, traceable to the IFCC reference measurement procedure, were performed by the European Reference Laboratory for HbA1c in Winterswijk, the Netherlands. Annual EQA reports for all participants were reviewed for analytical bias, following IFCC Task Force criteria [23]. Only the reports from Curaçao exceeded the biological variation limits and were therefore excluded.

2.3. National Food Consumption Data

MNI data were obtained from the Dutch National Food Consumption Survey (DNFCS) 2019–2021, conducted by the National Institute for Public Health and the Environment (RIVM). Detailed methodology is described by Sanderman-Nawijn et al. [24]. In short, it is a cross-sectional study performed on children and adults aged 1–79 living in the Netherlands. Annually 3570 participants completed online questionnaires and two non-consecutive 24-h dietary recalls. From this dataset, total energy intake (TEI) was extracted, along with macronutrient-specific data: total carbohydrate intake (TCI), total fat intake (TFI), and total protein intake (TPI). TEI is expressed in kilocalories, while MNI components are reported as a percentage of energy ± 95% confidence interval. Due to the study design, the extracted data had an equal distribution on age and sex ratio. Weighting for age and sex was applied to align with the HbA1c dataset.

2.4. National Sports Participation Data

PA data were retrieved from the Dutch National Sports Participation Index Survey (2018–2021), conducted in collaboration with the Dutch Olympic Committee and Dutch Sports Federation (NOC*NSF). In short, it is a cross-sectional study monthly performed on children and adults aged 5–80 living in the Netherlands. Monthly, about 3250 participants completed online questionnaires concerning sports activity, behaviour, frequency, etc. From this data, the Sports Participation Index (SPI) was derived, representing a weighted distribution across four categories: (1) no sports activity, (2) active 1–3 times/month, (3) active 4–9 times/month, and (4) active 10+ times/month [25]. Due to the study design, the extracted data had an equal distribution on age and sex ratio. Therefore, weighting factors were used to adjust for these variables to ensure comparability with the HbA1c data.

2.5. COVID-19

Information concerning lockdown periods during the COVID-19 pandemic in The Netherlands and Curaçao were retrieved from The Dutch Institute of Public Safety (NIPV), and the Dutch Ministry of Public Health (VWS) [26,27].

2.6. Data Transformation

Data were transformed into monthly and seasonal averages based on meteorological definitions (e.g., spring = 1 March–31 May).

2.7. HbA1c Prediction by PA and TEI

To correlate PA and MNI with HbA1c, only data from the overlapping period (2019–2021) were used.
Assuming that MNI (via TEI) positively influences HbA1c levels and PA negatively influences them, an algorithm was developed to predict monthly relative HbA1c values. Because MNI data are expressed as energy percentages (always totalling 100%), TEI was used instead as a single positive driver, reflecting the cumulative effect of all macronutrients, and expressed as an absolute number.
The absolute difference between the monthly averages and the average of the entire study period was calculated. By dividing these monthly differences by the study period average, the numbers become relative and therefore more comparable.
SPI values were multiplied by −1 to emphasize their hypothesized inverse effect on HbA1c formation. The prediction formula is as follows:
pHbA1cx = %TEIx + (−1 × %SPIx)
where
pHbA1cx = predicted HbA1c for month x;
%TEIx = relative TEI for month x;
%SPIx = relative SPI for month x.
Monthly predicted values were subsequently converted into seasonal averages.

2.8. Statistical Analysis and Calculations

Calculations were performed using Microsoft Excel 365 (Microsoft Corp., Seattle, WA, USA). Statistical analyses were conducted using GraphPad Prism 10.2.0 for Windows (GraphPad Software, San Diego, CA, USA). Group differences were evaluated using one-way ANOVA (Kruskal–Wallis test) or the non-parametric Mann–Whitney U test. Relationships were estimated by Pearson correlation coefficient. p values < 0.05 were considered statistically significant.

3. Results

3.1. HbA1c Results over Time and Seasonal Variation

A total of 5,635,920 HbA1c results were included, comprising 2,755,965 data points from females (48.9%) and 2,879,955 from males (51.1%). The average age was 65.2 years (range: 0.9–105 years). Of the total dataset, 0.7% represented individuals aged 1–17 years, while 99.3% corresponded to individuals aged 18 years and older. The mean HbA1c was 52.4 ± 0.01 mmol/mol (NGSP 6.95 ± 0.001%) (Table 1).
All HbA1c results were grouped by year and converted into monthly mean values as shown in Figure 1A. A significant and consistent increase in average HbA1c levels was observed over the four-year study period, with a total increase of 0.71 mmol/mol (NGSP 0.06%). Among males, this increase was 0.97 mmol/mol (NGSP 0.09%), which was notably higher than the 0.38 mmol/mol (NGSP 0.04%) increase observed in females (Figure 1A). These increases were statistically significant across all populations, exceeding the 95% confidence intervals.
When comparing annual averages, the years 2018 and 2019 ranged from 52.0 to 52.3 mmol/mol (NGSP 6.91 to 6.94%), while 2020 and 2021 increased to 52.5 to 52.9 mmol/mol (NGSP 6.95 to 6.99%), coinciding with several COVID-19 lockdown periods.
Conversion to seasonal values revealed a distinct pattern of seasonal variation as is shown in Figure 1B. All seasonal means differed significantly from each other (p < 0.0001). The lowest mean HbA1c level was observed in autumn (51.9 ± 0.02 mmol/mol; NGSP 6.90 ± 0.0018%), and the highest in winter (53.1 ± 0.02 mmol/mol; NGSP 7.01 ± 0.0018%), resulting in a mean seasonal difference of 1.2 mmol/mol (NGSP 0.11%).
Although data from Curaçao were excluded from the main dataset due to discrepancies in the male/female diabetes ratio and analytical bias, seasonal variation should not be influenced by these anomalies and was therefore separately evaluated. The purpose of this evaluation was to assess whether seasonal fluctuations were less or absent, given the region’s proximity to the equator, in comparison to The Netherlands (Figure 2A,B). The dataset contained 66,575 HbA1c results, and the observed seasonal difference was much smaller (0.4 mmol/mol; NGSP 0.037%) compared to the main dataset, and not statistically significant.
Notably, in accordance with the main dataset, mean values from 2018–2021 showed an increase of 1.4 mmol/mol (NGSP 0.128%) in the last two years, which overlapped with COVID-19 lockdown periods.

3.2. Macronutrient Intake (MNI) and Seasonal Variation

Data from the Dutch National Food Consumption Survey showed only minimal fluctuations over time in carbohydrate, protein, fat, and total energy intake (TEI): +1.25% Energy, +0.1% Energy, −0.5% Energy, and −63.5 kcal, respectively (Figure 3A). These variations were not statistically significant and remained within confidence intervals.
During the lockdown periods in 2020 and 2021, no clear changes were observed in the intake patterns of individual macronutrients. However, TEI reached its highest values during the summer of 2020, aligning with the first lockdown period. This increase was not observed during the second lockdown in 2021.
Seasonal variation was observed for all three macronutrients, and TEI, with peak values occurring in different seasons. Although some seasonal differences were statistically significant, absolute differences were marginal and therefore clinically negligible (Figure 3B–E).

3.3. Physical Activity (PA) and Seasonal Variation

Data from the National Sports Participation Database showed a 7.2% decrease in physical activity over the study period. Significant reductions were observed in 2020 and 2021, coinciding with national COVID-19 lockdowns. Notably, 2021 recorded the lowest overall PA levels (Figure 4A).
The highest activity levels were reported in summer/autumn, while the lowest were seen in winter/spring (Figure 4B). Seasonal means differed significantly between spring and summer and between autumn and winter (p < 0.0001).

3.4. HbA1c Prediction

Data from the HbA1c database, the National Food Consumption Survey, and the National Sports Participation Database were combined for the period June 2019 to July 2021.
Figure 5 presents the relative deviations from the mean for PA, TEI, and TEI+PA (predicted HbA1c), compared with the measured HbA1c seasonal values. TEI alone followed a curve that did not align with actual HbA1c values. Correlation analysis confirmed no significant association (p = 0.157; Pearson r = 0.286).
In contrast, both PA and TEI+PA showed curves that aligned with the seasonal HbA1c trend. Statistically significant correlations were observed for PA (p < 0.0001; Pearson r = 0.700) and for TEI+PA (p = 0.004; Pearson r = 0.541), suggesting that physical activity may be the primary driver of seasonal variability in HbA1c.

4. Discussion

This large-scale study is the first to suggest a relationship between HbA1c, physical activity (PA), and macronutrient intake (MNI) in the Dutch diabetes population, aiming to identify which of these two factors contributes most to the observed seasonal variation in average HbA1c levels. Although seasonal fluctuations in HbA1c have been described in several countries, few studies have analysed them at a national scale or explicitly compared lifestyle-related drivers. This DAF-study therefore addresses a clear knowledge gab in linking nationwide laboratory and lifestyle data.
Firstly, a clear seasonal variation in mean HbA1c values at the population level was observed. The lowest levels occurred in autumn, and the highest in winter, with a maximum amplitude of 1.2 mmol/mol (NGSP 0.11%), which aligns with previously published findings [8,9,10,11,12,13,14].
Despite limitations in the Curaçao dataset, the absence of seasonal variation in this population supports earlier research, indicating that seasonal fluctuations in HbA1c decrease closer to the equator and increase with greater distance from it, regardless of hemisphere [8,15].
Both PA and MNI are commonly proposed as primary contributors to seasonal HbA1c variation. Seasonal changes in weather and temperature influence activity patterns and the availability of seasonally dependent food products.
Because the HbA1c dataset lacked corresponding individual-level MNI and PA data, national datasets representing the general Dutch population were used. These were partially matched to the HbA1c data using age- and sex-based weighting factors.
Although the proportion of individuals with (pre)diabetes within these national datasets is unknown, their documentation confirms that (pre)diabetics are included as a subset. To validate whether people with diabetes follow similar seasonal PA trends as the general population, we consulted longitudinal data from the Dutch National Institute for Public Health and the Environment (RIVM), covering 2001–2022. These data, which report the percentage of the population meeting national PA guidelines, showed that from 2018 to 2021 [28], the diabetes population followed the same annual trend as non-diabetics—albeit at lower absolute levels (approximately 35% vs. 50%, respectively). This suggests that the PA dataset is sufficiently representative for this study.
Our findings show that PA patterns also display seasonal variation. The highest levels were observed in summer and autumn, and the lowest in winter and spring. These results are consistent with the findings of Duijvestijn et al. (2021) [29] and a 2009 review by Shephard et al. [30]. In modern society, most seasonal variation in PA can be attributed to leisure-time physical activity, particularly during summer.
With respect to total energy intake (TEI), we observed only a significant difference between the highest values in summer and those in autumn. According to dietary reference intake values from the Dutch Health Council and the European Food Safety Authority [31,32,33], all seasonal averages for macronutrients remained within recommended ranges: carbohydrate (55.0% energy/day; reference: 45–60%), fat (23.3%; reference: 20–40%), protein (22.0%; reference: 10–25%), and TEI (2060 kcal; reference: up to 2400 kcal/day). Although significant changes were seen in the individual macronutrients (Figure 3), the absolute differences were marginal and therefore clinically negligible. These results indicate no excessive MNI during any particular season, but rather a stable dietary pattern throughout the year. The slight summer increase may be attributed to vacation periods. This effect is also reported from continuous glucose monitoring data suggesting that seasonal, holiday, and behavioral changes over extended periods can influence glycemic trends [34]. Next to this, the summer of 2020 shows the highest seasonal caloric intake value, probably as a result of the fist COVID-19 lockdown period.
The MNI dataset also includes an unknown proportion of individuals with (pre)diabetes. According to recent Dutch government figures, approximately 13% of the national population may fall into this category [35], which is substantially lower than the nearly 100% representation in our HbA1c dataset. Nevertheless, given the year-round availability of energy-dense foods and the likelihood that individuals with (pre)diabetes engage in lifestyle interventions, dietary modifications, and/or pharmacological treatment, this dataset remains adequately representative.
To assess the relative influence of PA and MNI on seasonal HbA1c variation, we applied a simulation model that assumed a decreasing effect of PA and an increasing effect of MNI on HbA1c. The role of macronutrients in glycemic control has been widely studied, but there is limited consensus regarding the specific impact of fat and protein [21]. The exact composition of nutrients appears to play a role in determining whether they have a positive or negative effect on postprandial glucose levels and, by extension, on HbA1c [36]. Since detailed nutrient composition data were unavailable, we assumed that all macronutrients contribute equally to HbA1c formation.
Combining the effects of PA and MNI should, in theory, generate a predicted HbA1c trend that reflects the actual seasonal values. Although this simplified model does not quantify absolute differences in amplitude because of the absence of specific weighting factors for every variable, the direction and shape of the trends are sufficiently informative. Our findings show that adding PA to the MNI curve produces a pattern that closely mirrors the actual HbA1c data, with statistical analysis confirming a significant correlation. This supports the hypothesis that PA is the primary driver of seasonal HbA1c variation.
In addition to the seasonal variation, we also observed a steady increase in average HbA1c levels from 2018 to 2021. Calibration bias or drift as an interfering factor was ruled out by the check on external quality assessment reports from all the participating laboratories during this study. This increase, however, appears to be associated with a decrease in PA, while MNI seems to be a more consistent factor without much fluctuation. Evolutionarily, modern humans’ PA levels have decreased, and there is a continuous availability of energy-dense food, resulting in a positive energy balance. Over time this leads to the accumulation of body fat, increasing the risk of obesity and, consequently, diabetes, which poses a significant public health risk [37]. When examining the effects, particularly during the COVID-19 pandemic, it is notable that PA particularly decreased during lockdowns. Other studies have reported similar reductions in physical activity during lockdowns, especially in individuals over 60 years of age [38,39] which is exactly the age group in our DAF-study.
In contrast, the impact of the pandemic on energy intake remains unclear. Some studies report increased caloric intake [40], while others describe undernutrition [41]. Our data, however, do not show substantial changes in MNI, reinforcing the dominant role of PA in influencing HbA1c during this period.
The relatively sharp increase in average HbA1c during 2020–2021, compared to earlier years, strengthens the case for a link between declining PA and rising HbA1c levels.
Next to the seasonality, a steady increase in HbA1c is observed from 2018 to 2021 (Figure 1A). Although this increase is small in magnitude, it signals a worrisome trend that could reflect declining PA levels and worsening population-level glycemic control. Published longitudinal data are rare, dating from the pre-standardisation era, small in size, and lagging information on HbA1c analysis methods, and therefore unsuitable for trend evaluation with our DAF-study data [42].
This study has several limitations. Data from both the National Food Consumption Survey and the Dutch National Sports Participation Index Survey were obtained through self-reported questionnaires. While acceptable at a national survey level, they may not capture the nuanced behavioural changes most relevant for people with diabetes. Although this method has known drawbacks—such as recall bias and social desirability bias—previous reports have proven that self-reported data can still be sufficiently robust to support conclusions at the population level and remain valuable for policymakers and healthcare professionals.
The prediction model used to combine TEI, PA, and HbA1c is simplistic and likely oversimplifies the complex relationship. It assumes equal contribution of all macronutrients to HbA1c and treats PA as a uniform negative driver. More refined modeling, perhaps incorporating continuous glucose monitoring or dietary quality indices, would strengthen the argument. Future studies should consider multilevel modeling with stratification by age, sex, diabetes type, and treatment modality. Controls for confounders such as medication adherence, comorbidities, or socioeconomic status would also be valuable.
Our findings are particularly relevant for Western European countries with comparable climates, healthcare systems, and dietary habits. Similar national-level investigations in other Western European countries would allow cross-validation of results and support region-specific recommendations.
Furthermore, the study combined three distinct databases representing different population samples, which were aligned using weighting factors. As a result, the absence of individual-level linkage between HbA1c values and lifestyle variables introduces a major limitation. The study therefore cannot establish causality but only suggests associations at the population level. Nonetheless, our findings are consistent with, and strengthen, those of previously published studies in this field [21].

5. Conclusions

In conclusion, we demonstrate that the Dutch (pre)diabetes population exhibits a clear seasonal variation in mean HbA1c levels, which appears to be primarily driven by seasonal fluctuations in physical activity.
Events that significantly affect population-level physical activity—such as the COVID-19 lockdown periods—seem to have a direct impact on glycaemic control, as reflected by more profound increases in average HbA1c during those times. Therefore, policymakers should prioritize physical activity promotion during societal disruptions.
Lifestyle interventions have been shown to effectively prevent various forms of diabetes and improve both glycaemic and cardiometabolic outcomes, particularly through enhanced physical activity [43,44,45]. However, the success of such interventions depends heavily on sustained behavioural change and active promotion [46,47,48,49].
We therefore advocate for strong public health recommendations and supportive programs that emphasize the importance of initiating, maintaining, and intensifying physical activity across the population—particularly in winter months.

Author Contributions

Conceptualization, E.K. and C.W.; Formal Analysis, E.K.; Data curation, E.K.; Writing—Original Draft Preparation, E.K., C.W. and H.B.; Writing—Review and Editing, E.K., C.W., H.B., M.D., C.S., A.L., L.M.H., J.B., J.v.d.O., S.K., M.B., I.v.V., P.V., J.K. (Jurgen Kooren), S.C., K.M., M.S., J.K. (Johannes Krabbe), R.W., M.O., I.v.d.L., M.v.K., M.M., M.K., S.E. and R.d.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki. The Medical Research Ethics Committees United (MEC-U) evaluated that this study was not subject to the Medical Research Involving Human Subjects Act (WMO) of The Netherlands (MEC-U registration number W21.281).

Informed Consent Statement

This project was a secondary data analysis of two existing, deidentified databases.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author, E.K., upon reasonable request.

Acknowledgments

The authors would like to thank Jorn Knops and Jeroen Kiepe at the Dutch Olympic Committee and Dutch Sports Federation (NOC-NSF), Team Data and Sport Intelligence, for providing access to the Dutch National Sports Participation Index Survey 2018–2021 data. We would also like to thank the National Institute for Public Health and the Environment (RIVM) for granting access to the Dutch National Food Consumption Survey (DNFCS) 2019–2021 data. Special thanks to Marja Beukers from Data Management at RIVM for her support in navigating the database.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
PAPhysical activity
MNIMacronutrient intake
NGSPNational Glycohemoglobin Standardization Program
IFCCInternational Federation for Clinical Chemistry
EQAExternal Quality Assessment
TEITotal Energy Intake
TCITotal Carbohydrate Intake
TFITotal Fat Intake
TPITotal Protein Intake
SPISports Participation Index
ADAAmerican Diabetes Association
EASDEuropean Association for the Study of Diabetes

References

  1. Magliano, D.J.; Boyko, E.J.; IDF Diabetes Atlas 10th Edition Scientific Committee. IDF Diabetes Atlas, 10th ed.; IDF Diabetes Atlas; International Diabetes Federation: Brussels, Belgium, 2021. [Google Scholar]
  2. Diabetes Control and Complications Trial Research Group; Nathan, D.M.; Genuth, S.; Lachin, J.; Cleary, P.; Crofford, O.; Davis, M.; Rand, L.; Siebert, C. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N. Engl. J. Med. 1993, 329, 977–986. [Google Scholar] [CrossRef]
  3. UK Prospective Diabetes Study. IV. Characteristics of Newly Presenting Type 2 Diabetic Patients: Male Preponderance and Obesity at Different Ages. Multi-Center Study. Diabet. Med. 1988, 5, 154–159. [CrossRef]
  4. American Diabetes Association Professional Practice Committee; ElSayed, N.A.; McCoy, R.G.; Aleppo, G.; Balapattabi, K.; Beverly, E.A.; Briggs Early, K.; Bruemmer, D.; Ebekozien, O.; Echouffo-Tcheugui, J.B.; et al. 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2025. Diabetes Care 2025, 48 (Suppl. 1), S14–S26. [Google Scholar] [CrossRef]
  5. Davies, M.J.; Aroda, V.R.; Collins, B.S.; Gabbay, R.A.; Green, J.; Maruthur, N.M.; Rosas, S.E.; Del Prato, S.; Mathieu, C.; Mingrone, G.; et al. Management of Hyperglycaemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022, 65, 1925–1966. [Google Scholar] [CrossRef] [PubMed]
  6. Hanas, R.; John, G.; International HbA(1c) Consensus Committee. 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement. Clin. Chem. 2010, 56, 1362–1364. [Google Scholar] [CrossRef] [PubMed]
  7. International Expert Committee. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009, 32, 1327–1334. [Google Scholar] [CrossRef] [PubMed]
  8. Ferrie, C.D.; Sharpe, T.C.; Price, D.A.; Surtees, R.A. Seasonal Variation of Glycosylated Haemoglobin. Arch. Dis. Child. 1987, 62, 959–960. [Google Scholar] [CrossRef]
  9. Asplund, J. Seasonal Variation of HbA1c in Adult Diabetic Patients. Diabetes Care 1997, 20, 234. [Google Scholar] [CrossRef]
  10. Maguire, G.A.; Edwards, O.M. Seasonal Variation in Glycated Haemoglobin in Diabetics. Ann. Clin. Biochem. 2001, 38 Pt 1, 59–60. [Google Scholar] [CrossRef]
  11. Ishii, H.; Suzuki, H.; Baba, T.; Nakamura, K.; Watanabe, T. Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients. Diabetes Care 2001, 24, 1503. [Google Scholar] [CrossRef]
  12. Kim, Y.J.; Park, S.; Yi, W.; Yu, K.-S.; Kim, T.H.; Oh, T.J.; Choi, J.; Cho, Y.M. Seasonal Variation in Hemoglobin A1c in Korean Patients with Type 2 Diabetes Mellitus. J. Korean Med. Sci. 2014, 29, 550–555. [Google Scholar] [CrossRef]
  13. Pereira, M.T.R.e.P.; Lira, D.; Bacelar, C.; Oliveira, J.C.; de Carvalho, A.C. Seasonal Variation of Haemoglobin A1c in a Portuguese Adult Population. Arch. Endocrinol. Metab. 2015, 59, 231–235. [Google Scholar] [CrossRef]
  14. Tseng, C.-L.; Brimacombe, M.; Xie, M.; Rajan, M.; Wang, H.; Kolassa, J.; Crystal, S.; Chen, T.-C.; Pogach, L.; Safford, M. Seasonal Patterns in Monthly Hemoglobin A1c Values. Am. J. Epidemiol. 2005, 161, 565–574. [Google Scholar] [CrossRef]
  15. Higgins, T.; Saw, S.; Sikaris, K.; Wiley, C.L.; Cembrowski, G.C.; Lyon, A.W.; Khajuria, A.; Tran, D. Seasonal Variation in Hemoglobin A1c: Is It the Same in Both Hemispheres? J. Diabetes Sci. Technol. 2009, 3, 668–671. [Google Scholar] [CrossRef]
  16. Raphael, A.; Friger, M.; Biderman, A. Seasonal Variations in HbA1c among Type 2 Diabetes Patients on a Semi-Arid Climate between the Years 2005–2015. Prim. Care Diabetes 2021, 15, 502–506. [Google Scholar] [CrossRef]
  17. Heilbronn, L.K.; Noakes, M.; Clifton, P.M. Effect of Energy Restriction, Weight Loss, and Diet Composition on Plasma Lipids and Glucose in Patients with Type 2 Diabetes. Diabetes Care 1999, 22, 889–895. [Google Scholar] [CrossRef]
  18. Bonekamp, N.E.; van Damme, I.; Geleijnse, J.M.; Winkels, R.M.; Visseren, F.L.J.; Morris, P.B.; Koopal, C. Effect of Dietary Patterns on Cardiovascular Risk Factors in People with Type 2 Diabetes. A Systematic Review and Network Meta-Analysis. Diabetes Res. Clin. Pract. 2023, 195, 110207. [Google Scholar] [CrossRef] [PubMed]
  19. Garonzi, C.; Forsander, G.; Maffeis, C. Impact of Fat Intake on Blood Glucose Control and Cardiovascular Risk Factors in Children and Adolescents with Type 1 Diabetes. Nutrients 2021, 13, 2625. [Google Scholar] [CrossRef] [PubMed]
  20. Smart, C.E.M.; Evans, M.; O’Connell, S.M.; McElduff, P.; Lopez, P.E.; Jones, T.W.; Davis, E.A.; King, B.R. Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children with Type 1 Diabetes, and the Effect Is Additive. Diabetes Care 2013, 36, 3897–3902. [Google Scholar] [CrossRef]
  21. Furukawa, T.; Nishida, Y.; Hara, M.; Shimanoe, C.; Koga, K.; Iwasaka, C.; Higaki, Y.; Tanaka, K.; Nakashima, R.; Ikezaki, H.; et al. Effect of the Interaction between Physical Activity and Estimated Macronutrient Intake on HbA1c: Population-Based Cross-Sectional and Longitudinal Studies. BMJ Open Diabetes Res. Care 2022, 10, e002479. [Google Scholar] [CrossRef] [PubMed]
  22. Verstraeten, S.; Griffith-Lendering, M.; Pin, R. De Nationale Gezondheidsenquête Curaçao 2017; Volksgezondheid Instituut Curaçao: Willemstad, Curaçao, 2018; pp. 1–174. [Google Scholar]
  23. Weykamp, C.; John, G.; Gillery, P.; English, E.; Ji, L.; Lenters-Westra, E.; Little, R.R.; Roglic, G.; Sacks, D.B.; Takei, I.; et al. Investigation of 2 Models to Set and Evaluate Quality Targets for Hb A1c: Biological Variation and Sigma-Metrics. Clin. Chem. 2015, 61, 752–759. [Google Scholar] [CrossRef]
  24. Sanderman-Nawijn, E.; Brants, H.; Dinnissen, C.; Ocké, M.; van Rossum, C. Energy and Nutrient Intake in the Netherlands. Results of the Dutch National Food Consumption Survey 2019–2021; Rijksinstituut voor Volksgezondheid en Milieu RIVM: Bilthoven, The Netherlands, 2024. [Google Scholar] [CrossRef]
  25. NOC*NSF Landelijke Sportdeelname Index-NOCNSF. Available online: https://nocnsf.nl:/sportdeelnameindex (accessed on 27 August 2024).
  26. van Duin, M.; Luesink, M. Evaluatie COVID-19 Crisis in Curaçao; Nederlands Instituut Publieke Veiligheid (NIPV): Arnhem, The Netherlands, 2023; pp. 1–28. Available online: https://nipv.nl/wp-content/uploads/2024/02/20230802-NIPV-Evaluatie-COVID-19-crisis-in-Curacao.pdf (accessed on 27 August 2024).
  27. Coronavirus Tijdlijn. Available online: https://www.rijksoverheid.nl/onderwerpen/coronavirus-tijdlijn (accessed on 22 July 2025).
  28. National Institute for Public Health and the Enviroment, RIVM, Ministry of Health, Welfare and Sport. Beweegrichtlijnen|Sport en Bewegen in Cijfers. Available online: https://www.sportenbewegenincijfers.nl/kernindicatoren/beweegrichtlijnen (accessed on 29 September 2024).
  29. Duijvestijn, M.; Schurink, T.; van den Berg, S. Sport-En Beweeggedrag in 2020; RIVM-2021-0117; RIVM Rijksinstituut voor Volksgezondheid en Milieu: Bilthoven, The Netherlands, 2021. [Google Scholar] [CrossRef]
  30. Shephard, R.J.; Aoyagi, Y. Seasonal Variations in Physical Activity and Implications for Human Health. Eur. J. Appl. Physiol. 2009, 107, 251–271. [Google Scholar] [CrossRef]
  31. Health Council of the Netherlands. Dietary Reference Intakes: Energy, Proteins, Fats, and Digestible Carbohydrates; Gezondheidsraad: Den Haag, The Netherlands, 2001. [Google Scholar]
  32. EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). Scientific Opinion on Dietary Reference Values for Carbohydrates and Dietary Fibre. EFSA J. 2010, 8, 1462. [Google Scholar] [CrossRef]
  33. Ministerie van Volksgezondheid, Welzijn en Sport. Dietary Reference Values for Energy-Advisory Report-The Health Council of the Netherlands. Available online: https://www.healthcouncil.nl/documents/advisory-reports/2022/08/16/dietary-reference-values-for-energy (accessed on 10 November 2024).
  34. Belsare, P.; Bartolome, A.; Stanger, C.; Prioleau, T. Understanding Temporal Changes and Seasonal Variations in Glycemic Trends Using Wearable Data. Sci. Adv. 2023, 9, eadg2132. [Google Scholar] [CrossRef] [PubMed]
  35. Diabetes mellitus|Volksgezondheid en Zorg. Available online: https://www.vzinfo.nl/diabetes-mellitus (accessed on 22 July 2025).
  36. Bonsembiante, L.; Targher, G.; Maffeis, C. Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients 2021, 13, 3344. [Google Scholar] [CrossRef] [PubMed]
  37. Spence, C. Explaining Seasonal Patterns of Food Consumption. Int. J. Gastron. Food Sci. 2021, 24, 100332. [Google Scholar] [CrossRef]
  38. Oliveira, M.R.; Sudati, I.P.; Konzen, V.D.M.; de Campos, A.C.; Wibelinger, L.M.; Correa, C.; Miguel, F.M.; Silva, R.N.; Borghi-Silva, A. COVID-19 and the Impact on the Physical Activity Level of Elderly People: A Systematic Review. Exp. Gerontol. 2022, 159, 111675. [Google Scholar] [CrossRef]
  39. Wunsch, K.; Kienberger, K.; Niessner, C. Changes in Physical Activity Patterns Due to the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19, 2250. [Google Scholar] [CrossRef]
  40. O’Connell, M.; Smith, K.; Stroud, R. The Dietary Impact of the COVID-19 Pandemic. J. Health Econ. 2022, 84, 102641. [Google Scholar] [CrossRef]
  41. Visser, M.; Schaap, L.A.; Wijnhoven, H.A.H. Self-Reported Impact of the COVID-19 Pandemic on Nutrition and Physical Activity Behaviour in Dutch Older Adults Living Independently. Nutrients 2020, 12, 3708. [Google Scholar] [CrossRef]
  42. Liebl, A.; Mata, M.; Eschwège, E. Evaluation of Risk Factors for Development of Complications in Type II Diabetes in Europe. Diabetologia 2002, 45 (Suppl. 1), S23–S28. [Google Scholar] [CrossRef]
  43. Fritsche, A.; Wagner, R.; Heni, M.; Kantartzis, K.; Machann, J.; Schick, F.; Lehmann, R.; Peter, A.; Dannecker, C.; Fritsche, L.; et al. Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes 2021, 70, 2785–2795. [Google Scholar] [CrossRef]
  44. Sagastume, D.; Siero, I.; Mertens, E.; Cottam, J.; Colizzi, C.; Peñalvo, J.L. The Effectiveness of Lifestyle Interventions on Type 2 Diabetes and Gestational Diabetes Incidence and Cardiometabolic Outcomes: A Systematic Review and Meta-Analysis of Evidence from Low- and Middle-Income Countries. EClinicalMedicine 2022, 53, 101650. [Google Scholar] [CrossRef]
  45. Mukherji, A.B.; Lu, D.; Qin, F.; Hedlin, H.; Johannsen, N.M.; Chung, S.; Kobayashi, Y.; Haddad, F.; Lamendola, C.; Basina, M.; et al. Effectiveness of a Community-Based Structured Physical Activity Program for Adults with Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw. Open 2022, 5, e2247858. [Google Scholar] [CrossRef]
  46. Vilafranca-Cartagena, M.; Bonet-Augè, A.; Colillas-Malet, E.; Puiggrós-Binefa, A.; Tort-Nasarre, G. Physical Activity Interventions in People with Diabetes: A Systematic Review of The Qualitative Evidence. Healthcare 2024, 12, 1373. [Google Scholar] [CrossRef] [PubMed]
  47. Yom-Tov, E.; Feraru, G.; Kozdoba, M.; Mannor, S.; Tennenholtz, M.; Hochberg, I. Encouraging Physical Activity in Patients with Diabetes: Intervention Using a Reinforcement Learning System. J. Med. Internet Res. 2017, 19, e338. [Google Scholar] [CrossRef] [PubMed]
  48. Quirk, H.; Blake, H.; Tennyson, R.; Randell, T.L.; Glazebrook, C. Physical Activity Interventions in Children and Young People with Type 1 Diabetes Mellitus: A Systematic Review with Meta-Analysis. Diabet. Med. 2014, 31, 1163–1173. [Google Scholar] [CrossRef] [PubMed]
  49. Zhao, X.; Forbes, A.; Ghazaleh, H.A.; He, Q.; Huang, J.; Asaad, M.; Cheng, L.; Duaso, M. Interventions and Behaviour Change Techniques for Improving Physical Activity Level in Working-Age People (18–60 years) with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Int. J. Nurs. Stud. 2024, 160, 104884. [Google Scholar] [CrossRef]
Figure 1. (A) Mean monthly HbA1c values over time, including seasonal schedule. The red line represents the values for females, the blue line the values for males, and the grey line females and males combined. 95% CI is added to the combined line. The dotted lines show the regression lines with the regression equations in the left upper corner, corresponding by color and expressed for both IFCC (mmol/mol) as NGSP units (%). COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for HbA1c. The overall means are expressed with 95% CI. The statistical differences are indicated.
Figure 1. (A) Mean monthly HbA1c values over time, including seasonal schedule. The red line represents the values for females, the blue line the values for males, and the grey line females and males combined. 95% CI is added to the combined line. The dotted lines show the regression lines with the regression equations in the left upper corner, corresponding by color and expressed for both IFCC (mmol/mol) as NGSP units (%). COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for HbA1c. The overall means are expressed with 95% CI. The statistical differences are indicated.
Diabetology 06 00135 g001
Figure 2. (A,B) HbA1c values for Curaçao. (A) Mean monthly HbA1c values over time including seasonal schedule. The line represents women and men combined. 95% CI are indicated. The dotted line represents the regression line with the regression equation in the left upper corner. COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for HbA1c. The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Figure 2. (A,B) HbA1c values for Curaçao. (A) Mean monthly HbA1c values over time including seasonal schedule. The line represents women and men combined. 95% CI are indicated. The dotted line represents the regression line with the regression equation in the left upper corner. COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for HbA1c. The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Diabetology 06 00135 g002
Figure 3. (A) Mean monthly macronutrient intake, and energy intake values over time, including seasonal schedule. The lines represent women and men combined. 95% CI are indicated. The gray line shows the total carbohydrate intake, the green line the total energy intake, the blue line the total fat intake, and the red line the total protein intake. The dotted lines represent the regression lines with the regression equations in the left upper corner, corresponding by color. COVID-19 lockdown periods are indicated with brackets. (BE) Annual and overall seasonal means for: (B) Total Energy Intake per day (kcal), (C) Total Carbohydrate Intake per day (% Energy). (D) Total Protein Intake per day (% Energy), and (E) Total Fat Intake per day (% Energy). The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Figure 3. (A) Mean monthly macronutrient intake, and energy intake values over time, including seasonal schedule. The lines represent women and men combined. 95% CI are indicated. The gray line shows the total carbohydrate intake, the green line the total energy intake, the blue line the total fat intake, and the red line the total protein intake. The dotted lines represent the regression lines with the regression equations in the left upper corner, corresponding by color. COVID-19 lockdown periods are indicated with brackets. (BE) Annual and overall seasonal means for: (B) Total Energy Intake per day (kcal), (C) Total Carbohydrate Intake per day (% Energy). (D) Total Protein Intake per day (% Energy), and (E) Total Fat Intake per day (% Energy). The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Diabetology 06 00135 g003
Figure 4. (A) Mean monthly Sports Participation Index values over time, including seasonal schedule. The line represents women and men combined. 95% CI are indicated. The dotted line represents the regression line with the regression equation in the left upper corner. COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for Sports Participation Index. The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Figure 4. (A) Mean monthly Sports Participation Index values over time, including seasonal schedule. The line represents women and men combined. 95% CI are indicated. The dotted line represents the regression line with the regression equation in the left upper corner. COVID-19 lockdown periods are indicated with brackets. (B) Annual and overall seasonal means for Sports Participation Index. The overall means are expressed with 95% CI. The statistical differences are indicated (ns: not significant).
Diabetology 06 00135 g004
Figure 5. HbA1c prediction model based on physical activity (PA) and total energy intake (TEI). The model assumes that the total energy intake from macronutrients like carbohydrate, protein, and fat are positive drivers to induce HbA1c, and PA a negative driver that reduces the formation of HbA1c. The seasonal values are expressed as relative difference to the mean. Calculation details are described in the materials and method section. The continuous blue line represents de actual measured HbA1c values; the continuous green line the PA, the continuous brown line the TEI; the continuous gray line represents the predicted HbA1c value as the sum in which PA is subtracted from TEI. See the text for details.
Figure 5. HbA1c prediction model based on physical activity (PA) and total energy intake (TEI). The model assumes that the total energy intake from macronutrients like carbohydrate, protein, and fat are positive drivers to induce HbA1c, and PA a negative driver that reduces the formation of HbA1c. The seasonal values are expressed as relative difference to the mean. Calculation details are described in the materials and method section. The continuous blue line represents de actual measured HbA1c values; the continuous green line the PA, the continuous brown line the TEI; the continuous gray line represents the predicted HbA1c value as the sum in which PA is subtracted from TEI. See the text for details.
Diabetology 06 00135 g005
Table 1. Number of HbA1c results reported per season per year.
Table 1. Number of HbA1c results reported per season per year.
SpringSummerAutumnWinterAnnual Mean/
Total N
2018XHbA1c 52.9 (6.99) *
N 227,117
XHbA1c52.3 (6.94)51.6 (6.87)51.5 (6.73)52.9 (6.99) **52.0 (6.91)
N348,010326,414368,228347,245
2019XHbA1c52.7 (6.97)52.3 (6.94)51.6 (6.87)52.7 (6.97)52.3 (6.94)
N376,682338,322386,652368,016
2020XHbA1c53.2 (7.02)51.8 (6.89)52.2 (6.93)53.7 (7.06)52.5 (6.95)
N213,464358,450371,330352,560
2021XHbA1c53.3 (7.03)52.5 (6.95)52.2 (6.93)53.2 (7.02) ***52.9 (6.99)
N374,936363,433396,230118,631
Ntotal1,313,0921,386,6191,522,6401,413,5695,635,920
Xtotal HbA1c52.9 (6.99)52.1 (6.92)51.9 (6.90)53.1 (7.01)52.4 (6.95)
95% CI+/− 0.03 (0.003)+/− 0.02 (0.002)+/− 0.02 (0.002)+/− 0.02 (0.002)+/− 0.01 (0.001)
XHbA1c: Mean HbA1c value expressed in mmol/mol; % value between brackets. N: number of results. 95% CI: 95% confidence limit. * January and February 2018; ** December 2018, January 2019 and February 2019; *** December 2021.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kemna, E.; Bilo, H.; Deckers, M.; Slim, C.; Loot, A.; Henricks, L.M.; Brinkman, J.; Ouweland, J.v.d.; Kurstjens, S.; Bosma, M.; et al. The Dutch HbA1c Lifestyle Study (DAF-Study): Seasonal Variation of HbA1c in the Dutch Diabetes Population—Associations with Macronutrient Intake and Physical Activity. Diabetology 2025, 6, 135. https://doi.org/10.3390/diabetology6110135

AMA Style

Kemna E, Bilo H, Deckers M, Slim C, Loot A, Henricks LM, Brinkman J, Ouweland Jvd, Kurstjens S, Bosma M, et al. The Dutch HbA1c Lifestyle Study (DAF-Study): Seasonal Variation of HbA1c in the Dutch Diabetes Population—Associations with Macronutrient Intake and Physical Activity. Diabetology. 2025; 6(11):135. https://doi.org/10.3390/diabetology6110135

Chicago/Turabian Style

Kemna, Erwin, Henk Bilo, Martine Deckers, Christiaan Slim, Annemarieke Loot, Linda M. Henricks, Jacoline Brinkman, Jody van den Ouweland, Steef Kurstjens, Madeleen Bosma, and et al. 2025. "The Dutch HbA1c Lifestyle Study (DAF-Study): Seasonal Variation of HbA1c in the Dutch Diabetes Population—Associations with Macronutrient Intake and Physical Activity" Diabetology 6, no. 11: 135. https://doi.org/10.3390/diabetology6110135

APA Style

Kemna, E., Bilo, H., Deckers, M., Slim, C., Loot, A., Henricks, L. M., Brinkman, J., Ouweland, J. v. d., Kurstjens, S., Bosma, M., Vlodrop, I. v., Verschuure, P., Kooren, J., Coolen, S., Mohrmann, K., Schuijt, M., Krabbe, J., Wever, R., Oostendorp, M., ... Weykamp, C. (2025). The Dutch HbA1c Lifestyle Study (DAF-Study): Seasonal Variation of HbA1c in the Dutch Diabetes Population—Associations with Macronutrient Intake and Physical Activity. Diabetology, 6(11), 135. https://doi.org/10.3390/diabetology6110135

Article Metrics

Back to TopTop